Used in pharmaceutical research as a structural analog of sunitinib, a tyrosine kinase inhibitor. Shows potential in cancer therapy due to its ability to inhibit tumor cell proliferation and angiogenesis. Studied for activity against various kinase enzymes involved in signal transduction pathways that drive tumor growth. Commonly employed in structure-activity relationship (SAR) studies to develop more effective and selective anticancer agents. Also used as a reference compound in metabolic and toxicity studies during drug development.